{"id":"agt4","safety":{"commonSideEffects":[{"rate":"null","effect":"Cough"},{"rate":"null","effect":"Dizziness"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by blocking the action of angiotensin II, a potent vasoconstrictor, to lower blood pressure and reduce the risk of cardiovascular events.","oneSentence":"AGT4 is an angiotensin II receptor antagonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:00:11.234Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT05206578","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia","status":"UNKNOWN","sponsor":"Ahn-Gook Pharmaceuticals Co.,Ltd","startDate":"2020-12-08","conditions":"Primary Hypercholesterolemia","enrollment":264}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AGT4","genericName":"AGT4","companyName":"Ahn-Gook Pharmaceuticals Co.,Ltd","companyId":"ahn-gook-pharmaceuticals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AGT4 is an angiotensin II receptor antagonist. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}